Skip to content

Clinical trials

Phase 3 Diabetes Mellitus trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 3 Country / region: United States Clear all

305 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20014
20029
200313
200415
200516
200627
200718
200818
200924
201020
201117
201214
201318
201416
20154
201620
201712
20184
20195
20205
20212
20226
20232
20242
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed253
Terminated34
Active, not recruiting5
Unknown status5
Recruiting4
Withdrawn3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S99
AstraZeneca32
Eli Lilly and Company19
Takeda17
Pfizer10
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)8
Sanofi6
Emory University5
GlaxoSmithKline5
Allergan4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus305
Diabetes Mellitus, Type 2167
Diabetes Mellitus, Type 144
Glucose Metabolism Disorders26
Dyslipidemias17
Hypertension15
Metabolic Diseases15
Obesity15
Insulin Resistance13
Endocrine System Diseases12

Trials

Showing 1 to 25 of 305. Each trial links to its page on Pharma Observatory.

205 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.